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PAST
The aggressive and infiltrating behaviour of signet ring
cell (SRC) tumours may be associated with poor progno-
sis.1 Although multimodality treatment has become the
standard of care for oesophageal and junctional adenocar-
cinoma, the role of neoadjuvant therapy has been under
debate for SRC tumours. Still little is known about the
exact impact of SRC histology on the efficacy of multi-
modality treatment in oesophageal and junctional
adenocarcinoma.1,2 We, therefore, assessed the impact of
SRC histology on response to neoadjuvant therapy and
survival.
PRESENT
Despite SRC histology not being an independent pre-
dictor for overall or disease-free survival in this study,
tumours with an SRC component had a higher rate of
irradical (R1/R2) resections and more advanced patholog-
ical T-stage after neoadjuvant therapy compared with non-
SRC tumours.3 SRC tumours had a higher rate of irradical
resections and a more advanced pathological T-stage,
resulting in worse locoregional recurrence-free survival
after receiving nCT. On the contrary, following nCRT, no
statistically significant differences were found between
groups for overall and disease-free survival and patholog-
ical characteristics. Moreover, the SRC group had worse
disease-free survival compared with the non-SRC group
after receiving nCT. These results indicate that nCRT
could achieve comparable locoregional control, recurrence
rates, and survival as in patients with non-SRC tumours.
Given the behavioural features of SRCs, locoregional
control could be of major importance.
FUTURE
As biopsies are not always representative for the
pheno- and genotype of the entire tumour, they may not
be accurate enough to determine the percentage of SRC
present.1 However, Bekkar et al. compared nCRT with
surgery alone in[ 50% SRC tumours and found a sig-
nificant survival benefit and lower rates of recurrence
after nCRT.4 This study underlines the findings of the
present study that favourable oncologic outcomes after
nCRT could be achieved in SRC tumours, independent of
percentage.
Possible intensification of locoregional therapy, how-
ever, may still be needed, and larger, prospective studies
should be conducted stratifying for SRC histology to
establish nCRT as optimal treatment regimen for oeso-
phageal SRC tumours.
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